Enveric Biosciences

One of the most important scientific developments in psychedelic-inspired medicine may not be a clinical trial.

A recently published Nature paper suggests that different signalling pathways downstream of the 5-HT2A receptor may drive distinct biological effects, including neuroplasticity and hallucination.

For years, researchers have sought to understand whether the therapeutic benefits associated with psychedelics can be separated from the hallucinogenic experience.
The findings are helping shape the next generation of neuroplastogenic drug development and may influence how future compounds are designed.

Read the research:
https://www.nature.com/articles/s41586-025-10061-7

Enveric today reported financial results for the first quarter ended March 31, 2026, and provided a comprehensive business update. See it here: https://bit.ly/4uQd0dg